Captopril ameliorates myocarditis in acute experimental Chagas disease

Circulation

Volumn 107, Issue 17, 2003, Pages 2264-2269

  Leon, Juan S ^b   Wang, Kegiang ^b   Engman, David M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

Angiotensin; Collagen; Infection; Myocarditis; Myosin

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYOSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BRAZIL; CHAGAS DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; EXPERIMENTAL MODEL; FIBROSIS; FLUID INTAKE; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MALE; MORTALITY; MOUSE; MYOCARDITIS; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; PSEUDOCYST; TISSUE NECROSIS; TRYPANOSOMA CRUZI; UREA NITROGEN BLOOD LEVEL;

ACUTE DISEASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIBODIES, PROTOZOAN; CAPTOPRIL; CHAGAS CARDIOMYOPATHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSIS; HYPERSENSITIVITY, DELAYED; MALE; MICE; NECROSIS; PARASITEMIA; SURVIVAL ANALYSIS; TRYPANOSOMA CRUZI;

EID: 0038372753     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000062690.79456.D0     Document Type: Article

References (32)

1. Moncayo A. Progress towards interruption of transmission of Chagas disease. Mem Inst Oswaldo Cruz. 1999;94(suppl 1):401-404.
2. Rassi A Jr, Rassi A, Little WC. Chagas' heart disease. Clin Cardiol. 2000;23:883-889.
3. Godsel LM, Leon JS, Engman DM. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des. 2003;9:723-735.
4. Batlouni M, Barretto AC, Armaganijan D, et al. Treatment of mild and moderate cardiac failure with captopril: a multicenter study. Arq Bras Cardiol. 1992;58:417-421.
5. Roberti RR, Martinez EE, Andrade JL, et al. Chagas cardiomyopathy and captopril. Eur Heart J. 1992;13:966-970.
6. Bestetti RB, Dalbo CM, Freitas OC, et al. Noninvasive predictors of mortality for patients with Chagas' heart disease: a multivariate stepwise logistic regression study. Cardiology. 1994;84:261-267.
7. Scharfstein J, Schmitz V, Morandi V, et al. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med. 2000;192:1289-1300.
8. Maeda H, Akaike T, Sakata Y, et al. Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin. Agents Actions Suppl. 1993;42:159-165.
9. Maruo K, Akaike T, Ono T, et al. Involvement of bradykinin generation in intravascular dissemination of Vibrio vulnificus and prevention of invasion by a bradykinin antagonist. Infect Immun. 1998;66:866-869.
10. Reyes MP, Khatib R, Khatib G, et al. Prolonged captopril therapy in murine viral myocarditis. J Cardiovasc Pharmacol Ther. 1998;3:43-50.
11. Shiverick KT, Thomas LL, Alpert NR. Purification of cardiac myosin: application to hypertrophied myocardium. Biochem Biophys Acta. 1975; 393:124-133.
12. Leon JS, Godsel LM, Wang K, et al. Cardiac myosin autoimmunity in acute Chagas heart disease. Infect Immun. 2001;69:5643-5649.
13. Rezkalla S, Kloner RA, Khatib G, et al. Effect of metoprolol in acute Coxsackievirus B3 murine myocarditis. J Am Coll Cardiol. 1988;12: 412-414.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
15. Rezkalla S, Kloner RA, Khatib G, et al. Beneficial effects of captopril in acute Coxsackievirus B3 murine myocarditis. Circulation. 1990;81: 1039-1046.
16. Takada H, Kishimoto C, Hiraoka Y, et al. Captopril suppresses interstitial fibrin deposition in Coxsackievirus B3 myocarditis. Am J Physiol. 1997;272:.
17. Suzuki J, Matsubara H, Urakami M, et al. Rat angiotensin II (type IA) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993:73:439-447.
18. Araki M, Kanda T, Imai S, et al. Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. J Cardiovasc Pharmacol. 1995;26:61-5.
19. Kanda T, Araki M, Nakano M, et al. Chronic effect of losartan in a murine model of dilated cardiomyopathy: comparison with captopril. J Pharm Exp Ther. 1995;273:955-958.
20. Baba T, Kanda T, Kobayashi I. Reduction of cardiac endothelin-1 by angiotensin II type 1 receptor antagonist in viral myocarditis of mice. Life Sci. 2000;67:587-597.
21. Molteni A, Moulder JE, Cohen EF, et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol. 2000;76:523-532.
22. Cohen EP, Molteni A, Hill P, et al. Captopril preserves function and ultrastructure in experimental radiation nephropathy. Lab Invest. 1996; 75:349-360.
23. Weisinger RS, Blair-West JR, Denton DA, et al. Effect of angiotensin-converting enzyme inhibitor on salt appetite and thirst of BALB/c mice. Am J Physiol. 1990;259:R736-R740.
24. Baba T, Kanda T, Kobayashi I. Reduction of cardiac endothelin-1 by angiotensin II type 1 receptor antagonist in viral myocarditis of mice. Life Sci. 2000;67:587-597.
25. Tanaka A, Matsumori A, Wang W, et al. An angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. Circulation. 1994;90:2051-2055.
26. Araki M, Kanda T, Imai S, et al. Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. J Cardiovasc Pharmacol. 1995;26:61-65.
27. Stauss HM, Zhu YC, Redlich T, et al. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II. J Cardiovasc Risk. 1994;1:255-262.
28. Linz W, Scholkens BA. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol. 1992;105:771-772.
29. Gallagher AM, Yu H, Printz MP. Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension. 1998;32: 84-88.
30. Anning PB, Grocott-Mason RM, Lewis MJ. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart. Endothelium. 1997;5:265-275.
31. Chandra M, Tanowitz HB, Petkova SB, et al. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). Int J Parasitol. 2002;32:897-905.
32. Suzuki H, Matsumori A, Matoba Y, et al. Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis: an SH-dependent reduction of its expression and myocardial injury. J Clin Invest. 1993;91:2727-2733.